Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioReliance Launches Validated Assay
BioReliance has launched a fully validated assay which can sensitively detect the presence of Calicivirus 2117 in biological samples. The test is designed to provide manufacturers of biological
BioReliance has launched a fully validated assay which can sensitively detect the presence of Calicivirus 2117 in biological samples. The test is designed to provide manufacturers of biological
MD Biosciences (MDB) has launched MD Bioproducts. The new division allows MD Biosciences to expand it’s product offering for immunology and cell biology research. The company said that
Huebner has over 35 years of experience in the diagnostic industry, and has been worked for number of clinical diagnostic companies including Hybritech, Inc., Gen-Probe, Inc., Nanogen, Inc.
Merz Pharmaceuticals (Merz) has reported that its NT 201, botulinum toxin type A free from complexing proteins (also known as Xeomin in Europe and Canada), was more efficacious
Boston Scientific has received 510(k) clearance to market its WallFlex Biliary RX fully and partially covered stents, for the palliative treatment of malignant bile duct strictures from the
Ground Zero Pharma (GZP) has opened a new office in downtown Brisbane, Australia in July, to better support an expanding Australian clientele in taking their programs to the
The European Commission has approved Simponi (alone or in combination with methotrexate) as a once-monthly, subcutaneous therapy for the treatment of moderate-to-severe, active rheumatoid arthritis, active and progressive
Perrigo has received final approval from the FDA for its Abbreviated New Drug Application for over-the-counter Polyethylene Glycol 3350, Powder for Solution. Perrigo is expecting to begin shipping
PDS Biotechnology has completed GLP toxicology studies of its HPV-cancer product. The studies, which included pharmacokinetic (PK) and adsorption, bio-distribution and excretion (ADE) studies in addition to the
Enzon Pharmaceuticals has announced that the European Commission has approved its Cimzia for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA). Cimzia (certolizumab